Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 2;12(12):2001.
doi: 10.3390/jpm12122001.

SARS-CoV-2 Variants in COVID-19 Disease: A Focus on Disease Severity and Vaccine Immunity in Patients Admitted to the Emergency Department

Affiliations

SARS-CoV-2 Variants in COVID-19 Disease: A Focus on Disease Severity and Vaccine Immunity in Patients Admitted to the Emergency Department

Marta Fogolari et al. J Pers Med. .

Abstract

Tracking SARS-CoV-2 variants along with vaccinations are fundamental for severe COVID-19 disease prevention. A study was performed that focused on 43 patients with the SARS-CoV-2 infection who were admitted to the Emergency Department. RT-PCR-positive nasopharyngeal samples were sequenced using the MiSeq II system for variant detection. The main reason for Emergency Department admission was COVID-19 (67%), followed by other causes (33%); 51% patients were unvaccinated or vaccinated with a single dose and 49% had completed the vaccination course with two or three doses. Among the vaccinated group, 38% were admitted for COVID-19, versus 94.5% of the unvaccinated group. After admission, 50% of the vaccinated group and 36% of the unvaccinated group were discharged and allowed to go home, and 80% of the unvaccinated had no major comorbidities; 63% needed hospital admission and 5% required a stay in the Intensive Care Unit. Of these, 37% were vaccinated with 3 doses, 11% with two doses, 4% with a single dose, and 48% were unvaccinated. The 70% of the vaccinated patients who were admitted to hospital presented major comorbidities versus 38% of the unvaccinated group. Two unvaccinated patients that needed intensive care had relevant comorbidities and died. Genome sequencing showed the circulation of three omicron and two pure sub-lineages of omicron, including 22 BA.1, 12 BA.1.1, and 7 BA.2. Data showed the SARS-CoV-2 national and international migration patterns and how vaccination was useful for severe COVID-19 disease prevention.

Keywords: COVID-19; SARS-CoV-2; VOC; omicron; sequencing; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Causes for Emergency Department admission in the study population.
Figure 2
Figure 2
Genome coverage plotted against the mean threshold value of the RT-PCR cycle (CT score); colors represent different omicron sub-lineages (panel A). Frequency and distribution of the SARS-CoV-2 omicron sub-lineages from the whole-genome sequences generated within the study (panel B).

Similar articles

Cited by

References

    1. Tao K., Tzou P.L., Nouhin J., Gupta R.K., de Oliveira T., Kosakovsky Pond S.L., Fera D., Shafer R.W. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat. Rev. Genet. 2021;22:757–773. doi: 10.1038/s41576-021-00408-x. - DOI - PMC - PubMed
    1. WHO . SARS-CoV-2 Variants of Concern and Variants of Interest. World Health Organization; Geneva, Switzerland: 2021. [(accessed on 1 March 2021)]. Available online: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
    1. CDC . SARS-CoV-2 Variant Classifications and Definitions. Centers for Disease Control and Prevention; Atlanta, GA, USA: 2021. [(accessed on 1 March 2021)]. Available online: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html.
    1. The COVID-19 Genomics UK (COG-UK) Consortium An integrated national scale SARS-CoV-2 genomic surveillance network. Lancet Microbe. 2020;1:e99–e100. doi: 10.1016/S2666-5247(20)30054-9. - DOI - PMC - PubMed
    1. Rambaut A., Holmes E.C., O’Toole A., Hill V., McCrone J.T., Ruis C., du Plessis L., Pybus O.G. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 2020;5:1403–1407. doi: 10.1038/s41564-020-0770-5. - DOI - PMC - PubMed

LinkOut - more resources